Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease

Figures

• 

  Figure 1. Remote monitoring measures and NT‐proBNP. The multivariable models of steps per week (A), light physical activity (B), activity heart rate (C), Patient‐Reported Outcomes Measurement Information System (PROMIS) global health score (D), PROMIS physical function score (E), Seattle Angina Questionnaire (SAQ) overall score (F), SAQ physical limitations score (G), and Kansas City Cardiomyopathy Questionnaire (KCCQ) physical limitations score (H) for prediction of log NT‐proBNP are shown, with 95% confidence limits using multivariable adjusted restricted cubic splines with 3 knots (10th, 50th, and 90th percentiles). All models are adjusted for age, sex, and body mass index. NTproBNP indicates N‐terminal pro‐b‐type natriuretic peptide.

• 

  Figure 2. Remote monitoring measures and u‐hs‐cTnI. The multivariable models of steps per week (A), heart rate during rest (B), and heart rate during activity (C) for prediction of log troponin I are shown, with 95% confidence limits using multivariable adjusted restricted cubic splines with 3 knots (10th, 50th, and 90th percentiles). All models are adjusted for age, sex, and body mass index. u‐hs‐cTnI indicates ultra‐high sensitivity cardiac‐specific troponin I.

• 

  Figure 3. Remote monitoring measures and hs‐CRP. The multivariable models of Seattle Angina Questionnaire (SAQ) physical limitations score (A) and Kansas City Cardiomyopathy Questionnaire (KCCQ) physical limitations score (B) for prediction of log hs‐CRP are shown, with 95% confidence limits using multivariable adjusted restricted cubic splines with 3 knots (10th, 50th, and 90th percentiles). All models are adjusted for age, sex, and body mass index. hs‐CRP indicates high sensitivity C‐reactive protein.